caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1841200391

Apurva LapsiwalaMD

NephrologyMesquite, TXI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
477
Unique beneficiaries
—
Total services
1,503
Distinct HCPCS
13
Medicare payment
$124K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 883 Nephrology providers in TX — above median (cohort median 1,432).
REFERRAL NETWORK

Where Apurva Lapsiwala's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 32 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Medford Mccoy
Pathology · Dallas, TX
89778
Laboratory Corporation Of America
Clinical Laboratory · Dallas, TX
72178
Indrani Raman
Internal Medicine · Murphy, TX
56507
Madhavi Mallareddy
Nephrology · Mesquite, TX
52586
Brian Giles
Interventional Radiology · Fort Worth, TX
49454
Tayyab Malik
Rheumatology · Mckinney, TX
43784
Robert Rinkenberger
Cardiology · Plano, TX
43331
Thomas Seale
Interventional Radiology · Deland, FL
41332
David Zorinsky
Diagnostic Radiology · Dallas, TX
40289
Farah Masood
Internal Medicine · Sunnyvale, TX
40529
Fahad Najeeb
Internal Medicine · Sayre, PA
39547
REDISH, GREGORY39394
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$725
Payment records
24
By payment type
Food and Beverage$725
PRESCRIBING · PART D · 2024
Total Rx claims
1,482
Beneficiaries
—
Total drug cost
$425K
Distinct drugs
28
Brand share
24.6%
Top prescribed drugs
Furosemide150 claims
Dapagliflozin Propanediol142 claims
Losartan Potassium140 claims
Amlodipine Besylate139 claims
Calcitriol120 claims